MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer

Stem Cell Reports

Volumn 8, Issue 6, 2017, Pages 1497-1505

  Godlewski, Jakub ^a   Ferrer Luna, Ruben ^b   Rooj, Arun K ^a   Mineo, Marco ^a   Ricklefs, Franz ^a,c   Takeda, Yuji S ^a   Nowicki, M Oskar ^a   Salińska, Elżbieta ^d   Nakano, Ichiro ^e   Lee, Hakho ^f   Weissleder, Ralph ^f   Beroukhim, Rameen ^b   Chiocca, E Antonio ^a   Bronisz, Agnieszka ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e University of Alabama at Birmingham   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cancer heterogeneity; cancer stem cells; exosomes; extracellular vesicles; GBM; glioblastoma; microRNA; subtypes

Indexed keywords

MICRORNA; TRANSCRIPTOME; CD133 ANTIGEN; CD63 ANTIGEN; PROM1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CELL ENCAPSULATION; CELL SUBPOPULATION; CELL TRANSFER; CONTROLLED STUDY; EXOSOME; FEMALE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY CELL; PRIORITY JOURNAL; ANIMAL; BRAIN TUMOR; CYTOLOGY; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; TUMOR INVASION; XENOGRAFT;

AC133 ANTIGEN; ANIMALS; BRAIN NEOPLASMS; EXOSOMES; EXTRACELLULAR VESICLES; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PHENOTYPE; TETRASPANIN 30; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 85019367589     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2017.04.024     Document Type: Article

References (20)

1. Brennan, C.W., Verhaak, R.G., McKenna, A., Campos, B., Noushmehr, H., Salama, S.R., Zheng, S., Chakravarty, D., Sanborn, J.Z., Berman, S.H., et al. The somatic genomic landscape of glioblastoma. Cell 155 (2013), 462–477.
2. Bronisz, A., Wang, Y., Nowicki, M.O., Peruzzi, P., Ansari, K.I., Ogawa, D., Balaj, L., De Rienzo, G., Mineo, M., Nakano, I., et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 74 (2014), 738–750.
3. Brunet, J.P., Tamayo, P., Golub, T.R., Mesirov, J.P., Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. USA 101 (2004), 4164–4169.
4. Celiku, O., Johnson, S., Zhao, S., Camphausen, K., Shankavaram, U., Visualizing molecular profiles of glioblastoma with GBM-BioDP. PLoS One, 9, 2014, e101239.
5. Du, Z., Fei, T., Verhaak, R.G., Su, Z., Zhang, Y., Brown, M., Chen, Y., Liu, X.S., Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 20 (2013), 908–913.
6. Godlewski, J., Krichevsky, A.M., Johnson, M.D., Chiocca, E.A., Bronisz, A., Belonging to a network—microRNAs, extracellular vesicles, and the glioblastoma microenvironment. Neuro Oncol. 17 (2015), 652–662.
7. Johnson, D.R., O'Neill, B.P., Glioblastoma survival in the United States before and during the temozolomide era. J. Neuro Oncol. 107 (2012), 359–364.
8. Jones, D.L., Wagers, A.J., No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 9 (2008), 11–21.
9. Kim, S.H., Ezhilarasan, R., Phillips, E., Gallego-Perez, D., Sparks, A., Taylor, D., Ladner, K., Furuta, T., Sabit, H., Chhipa, R., et al. Serine/threonine kinase MLK4 determines mesenchymal identity in glioma stem cells in an NF-kappaB-dependent manner. Cancer Cell 29 (2016), 201–213.
10. Koppers-Lalic, D., Hackenberg, M., Bijnsdorp, I.V., van Eijndhoven, M.A., Sadek, P., Sie, D., Zini, N., Middeldorp, J.M., Ylstra, B., et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8 (2014), 1649–1658.
11. Lai, C.P., Kim, E.Y., Badr, C.E., Weissleder, R., Mempel, T.R., Tannous, B.A., Breakefield, X.O., Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat. Commun., 6, 2015, 7029.
12. Mao, P., Joshi, K., Li, J., Kim, S.H., Li, P., Santana-Santos, L., Luthra, S., Chandran, U.R., Benos, P.V., Smith, L., et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl. Acad. Sci. USA 110 (2013), 8644–8649.
13. Mineo, M., Ricklefs, F., Rooj, A.K., Lyons, S.M., Ivanov, P., Ansari, K.I., Nakano, I., Chiocca, E.A., Godlewski, J., Bronisz, A., The long non-coding RNA HIF1A-AS2 facilitates the maintenance of mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell Rep. 15 (2016), 2500–2509.
14. Patel, A.P., Tirosh, I., Trombetta, J.J., Shalek, A.K., Gillespie, S.M., Wakimoto, H., Cahill, D.P., Nahed, B.V., Curry, W.T., Martuza, R.L., et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344 (2014), 1396–1401.
15. Phillips, H.S., Kharbanda, S., Chen, R., Forrest, W.F., Soriano, R.H., Wu, T.D., Misra, A., Nigro, J.M., Colman, H., Soroceanu, L., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 (2006), 157–173.
16. Ricklefs, F., Mineo, M., Rooj, A.K., Nakano, I., Charest, A., Weissleder, R., Breakefield, X.O., Chiocca, E.A., Godlewski, J., Bronisz, A., Extracellular vesicles from high-grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity. Cancer Res. 76 (2016), 2876–2881.
17. Schonberg, D.L., Lubelski, D., Miller, T.E., Rich, J.N., Brain tumor stem cells: molecular characteristics and their impact on therapy. Mol. Aspects Med. 39 (2014), 82–101.
18. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T. Jr., Carter, B.S., Krichevsky, A.M., Breakefield, X.O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008), 1470–1476.
19. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17 (2010), 98–110.
20. Wong, H.K., Fatimy, R.E., Onodera, C., Wei, Z., Yi, M., Mohan, A., Gowrisankaran, S., Karmali, P., Marcusson, E., Wakimoto, H., et al. The cancer genome atlas analysis predicts MicroRNA for targeting cancer growth and vascularization in glioblastoma. Mol. Ther. 23 (2015), 1234–1247.